212.20MMarket Cap-2073P/E (TTM)
0.970High0.918Low185.36KVolume0.960Open0.948Pre Close174.29KTurnover0.09%Turnover RatioLossP/E (Static)227.44MShares1.54052wk High2.65P/B196.97MFloat Cap0.52052wk Low--Dividend TTM211.11MShs Float24.900Historical High--Div YieldTTM5.51%Amplitude0.254Historical Low0.940Avg Price1Lot Size
Vaxart Stock Forum
After hours, we can see this going to $1.05 and possibly $1.15
can see $1.15 coming
direct hit 🎯 $1.0
time to fly, looking for $1
Vaxart, Inc. (NASDAQ: VXRT) reported its Q2 2024 financial results and provided a business update. Key highlights include:
1. BARDA awarded Vaxart up to $453 million for a Phase 2b trial of its oral COVID-19 vaccine.
2. The company plans to initiate the 10,000-subject Phase 2b trial in H2 2024, pending FDA alignment.
3. Vaxart is in discussions with the FDA regarding norovirus vaccine data and potential next steps.
4. Q2 2024 financial results: $62.6 million in cash and inv...
Wow Earnings Killer 1517 % !!!
Show me your power!
hold for few days, finally...
No comment yet